A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis

Clinical trial NCT07080125 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07080125
Sponsor: Boehringer Ingelheim
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Interstitial Lung Diseases Systemic Sclerosis Associated Interstitial Lung Disease

Start date: 2025-06-17
Primary completion: 2033-12-31
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.